netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 21 of 21


Details
UPD sitematrix Changed from 0 to
30/06/2023 14:25:04
(rpaylor )
UPD FurtherInformation Changed from
  • Approved for wet age related macular degeneration in line with NICE.
  • Approved for diabetic macular oedema in line with NICE.
  • Approved for visual impairment caused by macular oedema secondary
30/06/2023 14:25:04
(rpaylor )
UPD Ranibizumab 10mg/1ml injection (Lucentis®) updated
30/06/2023 14:25:04
(rpaylor )
UPD sitematrix Changed from 0 to
30/06/2023 14:24:45
(rpaylor )
UPD FurtherInformation Changed from
  • Approved for wet age related macular degeneration in line with NICE.
  • Approved for diabetic macular oedema in line with NICE.
  • Approved for visual impairment caused by macular oedema secondary
30/06/2023 14:24:45
(rpaylor )
UPD Ranibizumab 10mg/1ml injection (Lucentis®) updated
30/06/2023 14:24:45
(rpaylor )
UPD sitematrix Changed from 0 to
30/06/2023 14:23:49
(rpaylor )
UPD FurtherInformation Changed from
  • Approved for wet age related macular degeneration in line with NICE.
  • Approved for diabetic macular oedema in line with NICE.
  • Approved for visual impairment caused by macular oedema secondary
30/06/2023 14:23:49
(rpaylor )
UPD Ranibizumab 10mg/1ml injection (Lucentis®) added note
30/06/2023 14:23:49
(rpaylor )
LDL Link Added : NICE TA637: Ranibizumab for treating diabetic retinopathy (terminated appraisal) : https://www.nice.org.uk/guidance/TA637
30/06/2023 14:21:34
(rpaylor )
UPD sitematrix Changed from 0 to
15/07/2022 10:37:19
(DavidS )
UPD FurtherInformation Changed from
15/07/2022 10:37:19
(DavidS )
UPD Ranibizumab 10mg/1ml injection (Lucentis®) updated formatting
15/07/2022 10:37:19
(DavidS )
UPD Ranibizumab 10mg/1ml injection (Lucentis®) updated
19/05/2021 16:12:07
(DavidS )
UPD Ranibizumab 10mg/1ml injection (Lucentis®) b
31/01/2017 13:58:47
(WhitehallJ )
UPD Ranibizumab 10mg/1ml injection (Lucentis®) updte
17/01/2017 09:48:32
(DavidS )
LDL Link Added : NICE TA 155 Ranibizumab and pegaptanib for the treatment of age-related macular degeneration : https://www.nice.org.uk/guidance/ta155
17/01/2017 09:47:38
(DavidS )
LDL Link Added : NICE TA 274 Ranibizumab for treating diabetic macular oedema : https://www.nice.org.uk/guidance/ta274
17/01/2017 09:47:10
(DavidS )
LDL Link Added : NICE TA 283 Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion : https://www.nice.org.uk/guidance/ta283
17/01/2017 09:46:38
(DavidS )
LDL Link Added : NICE TA 298 Ranibizumab for treating choroidal neovascularisation associated with pathological myopia : https://www.nice.org.uk/guidance/ta298
17/01/2017 09:46:02
(DavidS )
UPD Ranibizumab (Lucentis®) build
17/01/2017 09:42:44
(DavidS )

 

 
netFormulary